Biocon Ltd
NSE:BIOCON

Watchlist Manager
Biocon Ltd Logo
Biocon Ltd
NSE:BIOCON
Watchlist
Price: 335.8 INR 1.28% Market Closed
Market Cap: 403.2B INR
Have any thoughts about
Biocon Ltd?
Write Note

Biocon Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biocon Ltd
Operating Income Peer Comparison

Comparables:
524663
526139
Z
532039
HESTERBIO
PANACEABIO

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Biocon Ltd
NSE:BIOCON
Operating Income
â‚ą15B
CAGR 3-Years
18%
CAGR 5-Years
6%
CAGR 10-Years
12%
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Operating Income
-â‚ą202.8m
CAGR 3-Years
-119%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Operating Income
-â‚ą10m
CAGR 3-Years
54%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Operating Income
â‚ą99.8m
CAGR 3-Years
112%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Operating Income
â‚ą470.6m
CAGR 3-Years
-9%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Panacea Biotec Ltd
NSE:PANACEABIO
Operating Income
-â‚ą597m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A

See Also

What is Biocon Ltd's Operating Income?
Operating Income
15B INR

Based on the financial report for Sep 30, 2024, Biocon Ltd's Operating Income amounts to 15B INR.

What is Biocon Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
12%

Over the last year, the Operating Income growth was -11%. The average annual Operating Income growth rates for Biocon Ltd have been 18% over the past three years , 6% over the past five years , and 12% over the past ten years .

Back to Top